Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerus Corp (NQ: CERS )

1.670 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cerus Corp

< Previous 1 2 3 4 5 6 Next >
Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress
From Cerus Corporation
Via Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2023
From Cerus Corporation
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The widely followed growth investor keeps making moves. 
Via The Motley Fool
Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate
From Cerus Corporation
Via Business Wire
Cerus Earnings Perspective: Return On Capital Employed
Via Benzinga
Recap: Cerus Q1 Earnings
Via Benzinga
Cerus's Return On Capital Employed Overview
Via Benzinga
Cerus Corporation Announces First Quarter 2023 Financial Results
From Cerus Corporation
Via Business Wire
7 Best Cathie Wood Stocks for Your May 2023 Buy List
This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent. 
Via InvestorPlace
Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023
From Cerus Corporation
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The popular growth investor publishes her daily transactions. Cathie Wood keeps buying Tesla as well as some of her smaller holdings. 
Via The Motley Fool
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results
From Cerus Corporation
Via Business Wire
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The popular growth investor publishes her daily transactions. She keeps buying Tesla as well as some low-priced genetics specialists. 
Via The Motley Fool
S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Surges Over 200 Points; Crude Oil Rises 2%
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday. 
Via Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Companies That Fell Through 52-Week Lows Monday During Monday's morning trading, 14 companies set new 52-week lows. 
Via Benzinga
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Third Quarter Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.